9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... Hypertension #PAH ... #Treatment #Management
Persistent Air Leak (PAL) Management Algorithm

Persistent Air Leak = Air Leak > 5-7 days

Dr. Udit Chaddha
(PAL) Management ... Algorithm Persistent ... #Leak #PAL #Prolonged ... #Management #Algorithm ... #Treatment #Pulmonary
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... for Treatment & ... Polyarteritis Nodosa (PAN ... pubmed.ncbi.nlm.nih.gov/34235884/ PAN ... #Guidelines #algorithm
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #Management #Algorithm ... #treatment
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Polyarteritis Nodosa (PAN ... ) - Vasculitis Management ... Algorithm - ACR ... @MithuRheum #PAN ... #Treatment #ACR2021
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... hospitalization or emergency ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management